Image (18422beb 7f97 43aa 8f64 1d30aa8b07f7 907 2)
Montelukast Sodium
Product Images NDC 67296-1381
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 67296-1381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (57f07f65 1a14 4423 9da8 975664ca0684 01)
A line graph displaying change in height (cm) over weeks on treatment for three groups: Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo. The x-axis represents weeks on treatment from -19 to 56, and the y-axis shows change in height from -3 to 7 cm. Each group trend is indicated by different symbols and distinct lines.*
Structure (57f07f65 1a14 4423 9da8 975664ca0684 02)
Chemical structure of montelukast sodium shown as a detailed molecular diagram including aromatic rings, a chlorine atom, and sodium carboxylate functional group.*
Figure 2 (57f07f65 1a14 4423 9da8 975664ca0684 03)
A line graph showing the mean percent change from baseline over weeks in treatment comparing montelukast sodium and placebo. The x-axis represents weeks in treatment from 0 to 15, including a washout period after week 12. Montelukast sodium shows a higher increase over time compared to placebo, with values peaking around week 12 before declining during the washout. Data points include error bars indicating variability.*
Montelukast Sodium Tablets Usp, 10 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 04)
Montelukast Sodium Tablets, USP 10 mg film-coated tablets in a 30-tablet package. The label includes storage instructions and warnings to keep out of reach of children. Manufactured by Unichem Laboratories Ltd. and for Unichem Pharmaceuticals (USA), Inc.*
Montelukast Sodium Chewable Tablets Usp, 5 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 05)
Montelukast Sodium 5 mg chewable tablets, USP, for pediatric patients aged 6 to 14 years, in a bottle containing 30 tablets. Label includes storage instructions, phenylketonurics warning, and pharmacist dispensing guidance. Manufactured by Unichem Laboratories Ltd. and distributed by Unichem Pharmaceuticals (USA), Inc.*
Montelukast Sodium Chewable Tablets Usp, 4 mg-30t (57f07f65 1a14 4423 9da8 975664ca0684 06)
Montelukast Sodium 4 mg chewable tablets label featuring dosage strength, pediatric indication for ages 2-5 years, storage instructions, and warnings. The label includes manufacturer information for Unichem Laboratories Ltd. and Unichem Pharmaceuticals (USA), and indicates a package size of 30 tablets.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
